Session 5 - Pathophysiology of allergic disorders, inflammation; Treatment of non-allergic immune disorders
June 22, 2022
7:30-10:30 am CST
Sponsored by:

Check out our virtual exhibit
Moderators
Sven-Erik Dahlén, MD PhD
G. Walter Canonica, MD
Intro & Welcome
Sven-Erik Dahlén, MD PhD
7:30-7:45 am
Investigation of allergic airway inflammation in aged mice with Dermatophagoides farinae-induced asthma model
Shin Ohta
Abstract #22
7:45-8:00 am
New roles of IgA molecules in the pathogenesis of asthma: their involvement in airway inflammation and remodeling
Ken Ohta, MD, PhD
Abstract #24
8:00-8:15 am
Neuregulin-1 significantly reduces respiratory virus induced mortality
Mitchell H. Grayson, MD
Abstract #9
8:15-8:30 am
Effect of influenza infection on airways inflammation is mitigated by STAT6 inhibition
Christine T. McCusker, MSc, MD
Abstract #43
8:30-8:40 am
BREAK
8:40-8:55 am
Interferons Acutely and Directly Activate Vagal C-fibers Terminating in the Airways
Bradley J. Undem, PhD
Abstract #27
8:55-9:10 am
Allergen-induced olfactory neuroepithelial remodeling depends on nasal tuft cells and tuft cell-derived cysteinyl leukotrienes
Lora Bankova, MD
Abstract #20
9:10-9:25
Oligomeric histamine-releasing factor is an essential effector molecule for IgE-mediated allergic reactions
Yu Kawakami
Abstract #32
9:25-9:40 am
Azithromycin to Prevent Recurrent Wheeze Following Severe RSV bronchiolitis
Leonard Bacharier, MD
Abstract #44
9:40-9:55 am
Autoantibody-mediated Macrophage dysfunction impairs response to Infection in Severe Eosinophilic Asthma
Kate Miyasaki, BSc.
MSc. Candidate, Biochemistry and Biomedical Sciences
Abstract #59
9:55-10:10 am
IgE-mediated autoreactivity in atopic dermatitis correlates with the presence of comorbid atopic diseases
Inge Kortekaas Krohn, PhD
Abstract #4
10:10-10:15 am
Closing Remarks
G. Walter Canonica, MD
Regeneron Lecture
10:15-11:15 am
A Focus on Type 2 Inflammation in Disease
William W. Busse, MD
|